PT87207A - Process for preparing recombinant htlv-iii proteins and uses thereof - Google Patents

Process for preparing recombinant htlv-iii proteins and uses thereof

Info

Publication number
PT87207A
PT87207A PT87207A PT8720788A PT87207A PT 87207 A PT87207 A PT 87207A PT 87207 A PT87207 A PT 87207A PT 8720788 A PT8720788 A PT 8720788A PT 87207 A PT87207 A PT 87207A
Authority
PT
Portugal
Prior art keywords
preparing recombinant
iii proteins
recombinant htlv
htlv
proteins
Prior art date
Application number
PT87207A
Other languages
English (en)
Inventor
Scott D Putney
Debra Lynn
Kashayar Javaherian
William T Muller
John Farley
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of PT87207A publication Critical patent/PT87207A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT87207A 1987-10-09 1988-04-08 Process for preparing recombinant htlv-iii proteins and uses thereof PT87207A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10770387A 1987-10-09 1987-10-09

Publications (1)

Publication Number Publication Date
PT87207A true PT87207A (pt) 1989-07-31

Family

ID=22318013

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87207A PT87207A (pt) 1987-10-09 1988-04-08 Process for preparing recombinant htlv-iii proteins and uses thereof

Country Status (10)

Country Link
EP (1) EP0311228A3 (pt)
JP (1) JPH01193299A (pt)
KR (1) KR890006672A (pt)
AU (1) AU614535B2 (pt)
DK (1) DK196088A (pt)
FI (1) FI882741A7 (pt)
IL (1) IL86153A0 (pt)
NO (1) NO881502L (pt)
NZ (1) NZ224393A (pt)
PT (1) PT87207A (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
AU3928593A (en) * 1992-04-01 1993-11-08 Merck & Co., Inc. Recombinant human HIV-neutralizing monoclonal antibodies for prevention and treatment of HIV infection
EP0728015B1 (en) 1992-06-18 2006-03-08 Creagen, Inc. Method of producing a set of combinatorial polypeptide antigens
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
JP7172554B2 (ja) 2018-12-19 2022-11-16 スズキ株式会社 車両下部構造

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44186B (en) * 1978-12-22 1990-04-30 Biogen Nv Process for obtaining recombinant dnk molecules
JPS5761110A (en) * 1980-09-30 1982-04-13 Kitagawa Tekkosho:Kk Formation of columnar solidified portion in soft ground
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus

Also Published As

Publication number Publication date
FI882741L (fi) 1989-04-10
DK196088D0 (da) 1988-04-11
IL86153A0 (en) 1988-11-15
AU2117388A (en) 1989-04-27
EP0311228A2 (en) 1989-04-12
KR890006672A (ko) 1989-06-15
FI882741A7 (fi) 1989-04-10
AU614535B2 (en) 1991-09-05
NO881502D0 (no) 1988-04-07
JPH01193299A (ja) 1989-08-03
EP0311228A3 (en) 1990-05-02
FI882741A0 (fi) 1988-06-09
NO881502L (no) 1989-04-10
DK196088A (da) 1989-04-10
NZ224393A (en) 1990-08-28

Similar Documents

Publication Publication Date Title
FI90346C (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI883388L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten peptidien valmistamiseksi
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK518988A (da) Vanduoploeseligt polypeptidpraeparat
FI981380A0 (fi) Menetelmä HCV-polypeptidien valmistamiseksi
PT86600A (pt) Process for the preparation of anticoagulant peptides
ATA257190A (de) Virales polypeptid
DK565987A (da) Substituerede aminosyrer
FI881743L (fi) Menetelmä bifunktionaalisten proteiinien valmistamiseksi
DK353788A (da) Polypeptidderivater
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
FI871522L (fi) Menetelmä proteiinien renaturoimiseksi
FI885296A7 (fi) Rekombinantti HIV-2 polypeptidi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
IL86153A0 (en) Recombinant htlv-iii proteins and uses thereof
DK345087D0 (da) Protein
FI884652L (fi) Menetelmä t-PA-kaltaisten proteiinien tuotannon tehostamiseksi
DK354989A (da) Modificerede proteiner
GB8713559D0 (en) Structural proteins
FI893168A7 (fi) Menetelmä proteiinien valmistamiseksi
FI892323A7 (fi) Menetelmä 5-amino-7(substituoitu amino)-kinoliini-3-karboksyyli-happojen valmistamiseksi
ZA883261B (en) Recombinant htlv-iii proteins and uses thereof
IE881482L (en) Recombinant htlv-iii proteins

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19941024